HEMNOS clinical trials at UCSF
1 research study open to eligible people
Hemnos is a field of medical research. UCSF is running trials to test new treatments for liver cancer in children. These studies check if the treatments are safe and how well they work.
Showing trials for
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
open to eligible people ages 1-21
Open-label, dose escalation, multi-center, Phase I/II clinical trial to assess the safety/tolerability and determine the recommended Phase II Dose (RP2D) of ET140203 T-cells in pediatric subjects who are AFP-positive/HLA-A2-positive and have relapsed/refractory HB, HCN-NOS, or HCC.
San Francisco, California and other locations
Our lead scientists for HEMNOS research studies include Arun Rangaswami, MD.
Last updated: